INKON Life Technology Co Ltd (300143) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.052x

Based on the latest financial reports, INKON Life Technology Co Ltd (300143) has a cash flow conversion efficiency ratio of 0.052x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥71.76 Million ≈ $10.50 Million USD) by net assets (CN¥1.38 Billion ≈ $201.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INKON Life Technology Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

INKON Life Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how INKON Life Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

INKON Life Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of INKON Life Technology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Quanex Building Products NYSE:NX	0.026x
Renta 4 Banco S.A MC:R4	0.031x
Daishin Sec KO:003540	-0.415x
Sanxiang Co Ltd SHE:000863	0.011x
Anhui Huaheng Biotechnology Co. Ltd. A SHG:688639	-0.004x
Arrowhead Properties Ltd B JSE:FTB	0.046x
Beijing SL Pharmaceutical Co Ltd SHE:002038	0.013x
Risesun Real Estate Development Co Ltd SHE:002146	-0.025x

Annual Cash Flow Conversion Efficiency for INKON Life Technology Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of INKON Life Technology Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of INKON Life Technology Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.62 Billion ≈ $382.85 Million	CN¥340.83 Million ≈ $49.87 Million	0.130x	+24.53%
2024-12-31	CN¥2.48 Billion ≈ $362.66 Million	CN¥259.25 Million ≈ $37.94 Million	0.105x	-21.34%
2023-12-31	CN¥1.43 Billion ≈ $209.08 Million	CN¥190.01 Million ≈ $27.80 Million	0.133x	+9.04%
2022-12-31	CN¥1.32 Billion ≈ $192.77 Million	CN¥160.67 Million ≈ $23.51 Million	0.122x	+75.31%
2021-12-31	CN¥1.81 Billion ≈ $264.20 Million	CN¥125.61 Million ≈ $18.38 Million	0.070x	+83.91%
2020-12-31	CN¥2.24 Billion ≈ $327.88 Million	CN¥84.77 Million ≈ $12.40 Million	0.038x	+73.71%
2019-12-31	CN¥1.37 Billion ≈ $200.10 Million	CN¥29.78 Million ≈ $4.36 Million	0.022x	-54.84%
2018-12-31	CN¥2.07 Billion ≈ $302.49 Million	CN¥99.69 Million ≈ $14.59 Million	0.048x	-29.68%
2017-12-31	CN¥2.43 Billion ≈ $355.97 Million	CN¥166.82 Million ≈ $24.41 Million	0.069x	+237.48%
2016-12-31	CN¥2.20 Billion ≈ $321.31 Million	CN¥44.62 Million ≈ $6.53 Million	0.020x	-42.42%
2015-12-31	CN¥1.48 Billion ≈ $217.17 Million	CN¥52.37 Million ≈ $7.66 Million	0.035x	-42.87%
2014-12-31	CN¥343.97 Million ≈ $50.33 Million	CN¥21.25 Million ≈ $3.11 Million	0.062x	+192.22%
2013-12-31	CN¥643.30 Million ≈ $94.14 Million	CN¥13.60 Million ≈ $1.99 Million	0.021x	-36.66%
2012-12-31	CN¥810.78 Million ≈ $118.64 Million	CN¥27.06 Million ≈ $3.96 Million	0.033x	-71.28%
2011-12-31	CN¥785.85 Million ≈ $114.99 Million	CN¥91.32 Million ≈ $13.36 Million	0.116x	+37.33%
2010-12-31	CN¥727.00 Million ≈ $106.38 Million	CN¥61.51 Million ≈ $9.00 Million	0.085x	-61.27%
2009-12-31	CN¥116.90 Million ≈ $17.11 Million	CN¥25.54 Million ≈ $3.74 Million	0.218x	-11.98%
2008-12-31	CN¥81.55 Million ≈ $11.93 Million	CN¥20.24 Million ≈ $2.96 Million	0.248x	-41.95%
2007-12-31	CN¥74.89 Million ≈ $10.96 Million	CN¥32.02 Million ≈ $4.69 Million	0.428x	--

About INKON Life Technology Co Ltd

SHE:300143 China Medical Devices

Market Cap

$764.39 Million

CN¥5.22 Billion CNY

Market Cap Rank

#10273 Global

#2785 in China

Share Price

CN¥6.97

Change (1 day)

+0.43%

52-Week Range

CN¥6.83 - CN¥13.38

All Time High

CN¥29.11